Search filters

List of works by Elizabeth Cohen-Jonathan Moyal

A phase 1 dose-escalation study of the oral histone deacetylase inhibitor abexinostat in combination with standard hypofractionated radiotherapy in advanced solid tumors

scientific article

Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma

scientific article published on 7 April 2009

Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?

scientific article published on 8 August 2016

EANO guidelines for the diagnosis and treatment of ependymal tumors

scientific article published on 29 November 2017

EANO guidelines for the diagnosis and treatment of meningiomas

scientific article published on 30 August 2016

FGFR1/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarker

Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response

scientific article published on 13 April 2015

Phase I trial of tipifarnib (R115777) concurrent with radiotherapy in patients with glioblastoma multiforme

scientific article published on 14 June 2007

Recent advances in the biology and treatment of brain metastases of non-small cell lung cancer: summary of a multidisciplinary roundtable discussion.

scientific article

Sexual Quality of Life and Needs for Sexology Care of Cancer Patients Admitted for Radiotherapy: A 3-Month Cross-Sectional Study in a Regional Comprehensive Reference Cancer Center

scientific article published in April 2017

The Prognostic Significance of Lymphovascular Invasion on Biopsy Specimens in Lung Cancer Treated With Definitive Chemoradiotherapy

scientific article published on January 1, 2012

The β5/focal adhesion kinase/glycogen synthase kinase 3β integrin pathway in high-grade osteosarcoma: a protein expression profile predictive of response to neoadjuvant chemotherapy.

scientific article published on 8 July 2013

αvβ3 Integrin and Fibroblast growth factor receptor 1 (FGFR1): Prognostic factors in a phase I-II clinical trial associating continuous administration of Tipifarnib with radiotherapy for patients with newly diagnosed glioblastoma

scientific article published on 6 April 2013